Target intelligence / Profile preview

Bacterial enzymes and dentinal matrix proteins

Molecular classification
Enzyme (bacterial collagenases, proteases), Extracellular matrix protein (dentinal matrix proteins, e.g., type I collagen, SIBLING family)
01

Overview

Bacterial enzymes involved in dental caries primarily include collagenolytic proteases (such as M9 family metalloproteases and U32 family enzymes), which are produced by oral bacteria, notably Clostridium histolyticum, Porphyromonas, and Treponema denticola. These enzymes directly degrade dentinal matrix proteins such as type I collagen and members of the SIBLING family, facilitating the spread of bacteria and progression of carious lesions. Alongside bacterial proteases, host-derived matrix metalloproteinases (MMPs) substantially contribute to dentinal matrix breakdown following acid-mediated demineralization, further releasing bioactive matrix components with potential roles in reparative dentinogenesis or modulation of inflammation. Collectively, these proteases and their activity on dentinal matrix proteins constitute key targets for therapeutic strategies in the management of dental caries, targeting either enzyme inhibition or stabilization of matrix components to slow disease progression and promote tissue repair.

Other names
Bacterial collagenolytic proteasesMicrobial collagenasesMatrix metalloproteinases (for host enzymes)Dentin matrix components (DMCs)
02

Mechanism of action

Enzyme inhibition (blocking bacterial or host matrix metalloproteinases to prevent matrix breakdown); Metal ion chelation (e.g., zinc chelation to inhibit enzyme activity)

03

Biological functions

Extracellular matrix degradationTissue invasionSignal modulation (due to released bioactive fragments)Wound healing/regeneration (when DMCs are released and act on pulp cells)
04

Disease associations

Infection (mainly dental caries and periodontal disease)InflammationTissue destruction/collagen degradation (root caries, pulpal damage)
05

Safety considerations

Broad enzyme inhibition may interfere with normal wound healing and tissue remodelingEffects on oral microbiome balancePotential off-target activity if drugs are not selective for bacterial enzymes
06

Interacting drugs

Chlorhexidine (broad-spectrum MMP inhibitor used to slow dentin matrix degradation)

2 more in the full profile.

07

Biomarkers

Increased expression/activity of MMP-2, MMP-8, MMP-9, MMP-13, MMP-20 in carious dentinDetection of genes encoding bacterial collagenolytic proteases in root/coronal caries biofilms

Beyond the preview

Go deeper on Bacterial enzymes and dentinal matrix proteins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial enzymes and dentinal matrix proteins.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call